There is a need for comprehensive data on the long-term effects of weight loss drugs such as semaglutide or tirzapatide, as well as strategies for once people stop using them, argues a multidisciplinary team led by researchers from UCL, including Dr Adrian Brown (UCL Medicine).
Read: MSN, More: UCL News